OakChart

Hims & Hers Health Inc

HIMSHealthcare·Drug Manufacturers - Specialty & Generic·USA·Mid·NYSE·Nov 11 • 9:56 AM ET

19.42+0.29 (1.51%)
2026-11-11 15:56 CET
Market cap
4,463.30 USD m
Revenue, TTM
2,869.51 USD m
Net income, TTM
-190.84 USD m
Free cash flow, TTM
11.63 USD m
EPS diluted, TTM
-0.83
P/E
-
Compare

Price

HIMS against its 20, 50 and 200-day averages
2050200miss
20.0025.0030.0035.0040.0030.6M61.2MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26HIMSclose 19.4220-day 26.6150-day 27.92200-day 26.7719.42

59.8% under 48.34 on 4 Nov 2025. Last 15 sessions, 63.8% high to low

Profile

HIMS
52-week range, 21% of the way up
13.7441.28

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

IndexRUT
Employees2442
IPOSep 13, 2019
Beta2.55
ATR, 14d2.23
Rel volume2.91
Short float24.38%
Insider own9.19%
Inst own66.53%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap4.53B
Enterprise Value5.38B
Income-190.84M
Sales2.87B
Book/sh1.52
Cash/sh3.05
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees2442
IPOSep 13, 2019

Ratios

P/E-
Forward P/E453.84
PEG-
P/S1.58
P/B12.81
P/C6.36
P/FCF389.59
EV/EBITDA79.68
EV/Sales1.87
Quick Ratio0.84
Current Ratio0.92
Debt/Eq4.39
LT Debt/Eq4.36
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.83
EPS next Y0.04
EPS next Q-0.01
EPS this Y-265.93%
EPS next Y105.06%
EPS next 5Y-20.91%
EPS past 3/5Y- -
Sales past 3/5Y64.55% 73.63%
EPS Y/Y TTM-237.51%
Sales Y/Y TTM29.79%
EPS Q/Q-322.87%
Sales Q/Q48.65%
EarningsNov 09 AMC
EPS/Sales Surpr.-348.67% -0.31%

Ownership

Insider Own9.19%
Insider Trans-1.24%
Inst Own66.53%
Inst Trans-0.55%
ROA-6.60%
ROE-40.77%
ROIC-10.02%
Gross Margin49.97%
Oper. Margin-1.40%
Profit Margin-6.65%
SMA20-27.02%
SMA50-30.45%
SMA200-27.44%
Trades-

Technical

Shs Outstand226.02M
Shs Float211.88M
Short Float24.38%
Short Ratio4.27
Short Interest51.66M
52W High41.28 -52.96%
52W Low13.74 41.34%
Volatility13.85% 8.37%
ATR (14)2.23
RSI (14)30.57
Beta2.55
Rel Volume2.91
Avg Volume12.10M
Volume3,997,854

Performance

Perf Week-27.16%
Perf Month-34.64%
Perf Quarter-32.50%
Perf Half Y-19.55%
Perf YTD-40.19%
Perf Year-51.15%
Perf 3Y185.17%
Perf 5Y152.21%
Perf 10Y-
Recom2.53
Target Price29.51
Prev Close19.13
Price19.42
Change %1.51%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 11, 2026ResumedJJP MorganNeutral$32+64.8%
May 12, 2026ReiteratedNNeedhamBuy$30 → $35+80.2%
Apr 24, 2026InitiatedJJP MorganOverweight$35+80.2%
Mar 10, 2026UpgradeCCitigroupSell → Neutral$24+23.6%
Mar 10, 2026UpgradeBBofA SecuritiesUnderperform → Neutral$23+18.4%
Mar 09, 2026UpgradeNNeedhamHold → Buy$30+54.5%
Feb 24, 2026DowngradeBBTIG ResearchBuy → Neutral
Jan 12, 2026InitiatedEEvercore ISIIn-line$33+69.9%
Dec 09, 2025InitiatedBBarclaysOverweight$48+147.2%
Oct 21, 2025InitiatedKKeyBanc Capital MarketsSector Weight

Peers

Mkt cap
TickerCompanyMkt cap
LFMDLifeMD Inc84.59M
TDOCTeladoc Health Inc1.62B
GDRXGoodRx Holdings Inc1.21B
WWWW International Inc128.49M
NVONovo Nordisk ADR134.89B
DOCSDoximity Inc5.74B
OSCROscar Health Inc10.19B
AMWLAmerican Well Corp208.45M
LLYLilly(Eli) & Co1332.64B
PHRPhreesia Inc785.82M

Insider trading

latest 14 of 94
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Boughton SoleilChief Legal OfficerOct 28 '26Sale27.603,46295,551293,886Oct 29 04:11 PM
Boughton SoleilOfficerOct 28 '26Proposed Sale27.603,46295,551Oct 28 09:50 AM
Boughton SoleilChief Legal OfficerOct 14 '26Sale29.063,461100,577297,348Oct 15 04:44 PM
Boughton SoleilOfficerOct 14 '26Proposed Sale29.063,461100,577Oct 14 09:44 AM
Okupe OluyemiChief Financial OfficerOct 01 '26Sale29.702,00059,400234,527Oct 02 04:32 PM
Boughton SoleilChief Legal OfficerSep 30 '26Sale29.173,461100,957300,809Oct 02 04:31 PM
Okupe OluyemiOfficerOct 01 '26Proposed Sale29.702,00059,400Oct 01 12:05 PM
Boughton SoleilOfficerSep 30 '26Proposed Sale29.173,461100,957Sep 30 10:31 AM
Okupe OluyemiChief Financial OfficerSep 22 '26Option Exercise5.0114,00070,140265,804Sep 23 04:17 PM
Okupe OluyemiChief Financial OfficerSep 22 '26Sale29.9529,277876,846236,527Sep 23 04:17 PM
Okupe OluyemiOfficerSep 22 '26Proposed Sale29.9529,277876,846Sep 22 12:12 PM
Okupe OluyemiChief Financial OfficerSep 17 '26Sale28.8212,313354,861251,804Sep 18 04:17 PM
Boughton SoleilChief Legal OfficerSep 16 '26Sale27.866,236173,735304,270Sep 17 04:17 PM
Chi MichaelChief Operating OfficerSep 15 '26Sale28.3914,027398,227456,660Sep 17 04:17 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IJHiShares Core S&P Mid-Cap ETFAUM: 124.48B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
MDYState Street SPDR S&P MIDCAP 400 ETF TrustAUM: 26.22B
IJKiShares S&P Mid-Cap 400 Growth ETFAUM: 10.46B

News

latest 14 of 103
  • Hims & Hers Faces A Transition Year Amid Increasing AI Investments, Says KeyBanc Expects Lower Pricing To Weigh On FY2027-2028 Earnings Outlook (Stocktwits)
  • Five US states join FTC suit against Hims & Hers over privacy practices (Reuters) -16.61%
  • HIMS Stock Faces Dual Blow From Expanded FTC Privacy Lawsuit After Selloff Driven By Q3 Subscriber Loss (Stocktwits)
  • 4 Post-Earnings Losers Drawing Unusual Options Volume (Schaeffer's Research)
  • Hims & Hers stock sinks after Q3 results, outlook disappoints (Yahoo Finance)
  • Loading…
  • HIMS May See Heightened Gyrations As Weight-Loss Drug Trends Fuel Subscriber Uncertainty, Jefferies Warns Stock Hits 7-Month Lows (Stocktwits)
  • Hims & Hers cuts 2026 earnings outlook despite 49% revenue growth (Proactive)
  • Premarket movers: Sanmina, AAON surge; Hims & Hers, Rocket Lab fall (Investing.com)
  • Nvidia, Hims & Hers, JBS, Take-Two, and More Stocks That Explain Today's Market (Barrons.com)
  • Hims & Hers Plans November Launch of Peptide Treatments as Higher Costs Weigh on Profit Outlook (InvestorsHub)
  • HIMS Stock Slides Overnight: Retail Bets On Peptides Comeback As Stanford Neuroscientist Joins Board (Stocktwits)
  • Hims & Hers Accelerates Revenue 49%, But An EPS Miss, Third EBITDA Cut And First Subscriber Decline Undercut The Growth Story (Earnings Whispers) -11.77%
  • HIMS Stock Tumbles After-Hours On Surprise Q3 Loss And Cut Profit Outlook: Retail Demands Answers (Stocktwits)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-09-0.1400.056-0.140890.37893.1312
2026Q22026-08-10-0.370-0.050-0.372753.21698.912
2026Q12026-05-11-0.4000.025-0.403608.1616.8412
2025Q42026-02-230.0800.0400.089617.82619.2311
2025Q32025-11-030.0600.0940.063598.98580.2412
2025Q22025-08-040.1700.1510.169544.83551.679
2025Q12025-05-050.2000.1210.201586.01538.5911
2024Q42025-02-240.1100.1130.108481.14470.859
2024Q32024-11-040.3270.1110.322401.56382.210
2024Q22024-08-050.0600.0450.057315.65304.667
2024Q12024-05-060.0500.0100.049278.17270.376
2023Q42024-02-260.010-0.0220.006246.62246.475
2023Q32023-11-06-0.040-0.036-0.036226.7220.085
2023Q22023-08-07-0.030-0.049-0.034207.91204.955
2023Q12023-05-08-0.050-0.021-0.049190.77179.089
2022Q42023-02-27-0.050-0.059-0.053167.2161.175

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY-0.193-0.276-0.512148.79144.29
2021FY-0.580-0.365-0.576271.88264.2
2022FY-0.320-0.322-0.321526.92520.9
2023FY-0.110-0.132-0.113872871.89
2024FY0.5300.5400.5321,4771,467
2025FY0.5100.4640.5102,3482,349
2026FY--0.846--3,158
2027FY-0.043--3,902
2028FY-0.252--4,439
2029FY-0.743--4,905
2030FY-0.850--4,641

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-101219903.128811,046
2026Q4S2026-11-091220953.81899.211,046
2026Q4S2026-11-061220953.81899.211,046
2026Q4S2026-11-041220953.41899.211,046
2026Q4S2026-10-251230953.41899.211,046
2026Q4S2026-10-2312120953.41899.211,046
2026Q4S2026-10-1912120953.41899.211,046
2026Q4S2026-09-2512120953.4899.211,046
2026Q4S2026-09-1013130952.64899.211,046
2026Q4S2026-09-0913130952.68899.211,046
2026Q4S2026-09-0212120952.9899.211,046
2026Q4S2026-08-2112120949.37899.211,046
2026Q4S2026-08-2012110934.28728.51,046
2026Q4S2026-08-1113110925.49728.51,046

Estimate history

EPS, annual0.241-0.512-0.576-0.321-0.1130.5320.512-0.8277
Period2019202020212022202320242025TTM
EPS, quarterly0.3220.1080.2010.1690.0630.089-0.403-0.372-0.141
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual0148.757271.878526.9168721476.5142347.6372869.51
Period2019202020212022202320242025TTM
Sales, quarterly401.556481.139586.01544.833598.976617.818608.104753.214890.373
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual25.15646.026204.792208.429213.482220.837227.246234.398
Period2019202020212022202320242025MRQ
Shares, quarterly217.816220.837223.584225.759227.499227.246230.704233.298234.398
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue2,869.512,347.641,476.51872.00526.92271.88148.760.00
Cost of Goods Sold Incl. D&A1,435.63955.21506.27166.57125.6771.4640.360.00
Gross Profit1,433.881,392.43970.25705.43401.25200.42108.390.00
Selling, General and Administrative Excl. Other1,474.101,270.74902.24738.89469.72315.46123.541.31
Research and Development212.19149.30------
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-40.22121.6968.00-33.46-68.48-115.04-15.14-1.31
Interest Expense--0.000.000.000.000.010.00
Unusual Expense191.3320.896.10-2.930.15-3.803.10-5.50
Net Income Before Taxes-222.08123.9271.71-21.57-65.71-110.80-17.996.05
Income Taxes-31.24-4.44-54.331.98-0.03-3.140.130.00
Consolidated Net Income-190.84128.37126.04-23.55-65.68-107.66-18.116.05
Net Income From Continuing Operations-190.84128.37126.04-23.55-65.68-107.66-18.116.05
Net Income-190.84128.37126.04-23.55-65.68-107.66-18.116.05
EPS (Recurring)-0.240.570.55-0.12-0.32-0.59-0.450.09
EPS (Basic, Before Extraordinaries)-0.830.570.58-0.11-0.32-0.58-0.510.24
EPS (Diluted)-0.830.510.53-0.11-0.32-0.58-0.510.24
EBITDA67.51176.1985.09-23.95-61.00-110.97-14.09-1.31
Non-Operating Income (Expense)9.4723.139.818.962.920.450.271.86
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense140.57106.8472.9352.2033.8349.064.26-
Price To Earnings Ratio--55.93-----
Price To Sales Ratio2.433.573.882.142.494.503.47-
Gross Margin49.9759.3165.7180.9076.1573.7272.87-
Operating Margin-1.405.184.61-3.84-13.00-42.31-10.18-
Net Margin-6.655.478.54-2.70-12.46-39.60-12.18-
Shares Outstanding234.40227.25220.84213.48208.43204.7946.0325.16
Market Capitalization4,463.304,463.305,282.821,886.751,331.611,331.18367.28249.05

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue890.37753.21608.10617.82598.98544.83586.01481.14
Cost of Goods Sold Incl. D&A488.37367.89307.82271.55233.77195.13218.35175.74
Gross Profit402.00385.32300.28346.27365.21349.71367.66305.40
Selling, General and Administrative Excl. Other423.31400.40316.75333.63347.03316.75309.74282.64
Research and Development69.3954.9046.9440.9640.5837.8529.91-
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-21.30-15.08-16.4712.6418.1832.9557.9222.76
Interest Expense------0.000.00
Unusual Expense19.9181.5989.180.6413.996.230.024.16
Net Income Before Taxes-46.25-92.63-101.5518.3512.2232.8560.4922.29
Income Taxes-13.21-6.34-9.44-2.25-3.55-9.6511.01-3.73
Consolidated Net Income-33.04-86.29-92.1120.6015.7742.5149.4826.02
Net Income From Continuing Operations-33.04-86.29-92.1120.6015.7742.5149.4826.02
Net Income-33.04-86.29-92.1120.6015.7742.5149.4826.02
EPS (Recurring)-0.08-0.13-0.130.090.100.190.200.12
EPS (Basic, Before Extraordinaries)-0.14-0.37-0.400.090.070.190.220.12
EPS (Diluted)-0.14-0.37-0.400.090.060.170.200.11
EBITDA16.9114.395.4830.7335.8443.4266.2028.82
Non-Operating Income (Expense)-5.044.044.106.368.046.132.603.69
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense50.9433.2729.1227.2531.7428.2219.6419.24
Price To Earnings Ratio--39.7660.0370.9972.5655.2555.93
Price To Sales Ratio2.433.122.003.436.386.364.083.94
Gross Margin45.1551.1649.3856.0560.9764.1962.7463.47
Operating Margin-2.39-2.00-2.712.053.036.059.884.73
Net Margin-3.71-11.46-15.153.332.637.808.445.41
Shares Outstanding234.40233.30230.70227.25227.50225.76223.58220.84
Market Capitalization4,463.308,024.654,732.017,391.7612,819.8511,158.036,565.015,282.82

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments577.49300.25220.98179.62247.27100.211.51
Short Term Receivables32.156.085.713.233.580.750.00
Inventories115.7364.4322.4621.5613.563.540.00
Other Current Assets42.2625.0715.9012.185.504.650.15
Total Current Assets767.64395.83265.05216.59269.90109.161.66
Net Property, Plant & Equipment448.9892.9645.734.945.110.000.00
Total Investments and Advances351.260.860.860.860.861.01203.11
Intangible Assets474.44156.14129.46132.72136.770.060.00
Deferred Tax Assets82.7178.87-----
Other Assets29.680.150.0911.237.948.480.00
Total Assets2,154.70724.81441.19366.34420.58118.70204.77
Short Term Debt Incl. Current Port. of LT Debt4.841.891.281.661.360.000.00
Accounts Payable143.2891.1843.0732.3619.648.070.02
Income Tax Payable9.64-2.01----
Other Current Liabilities246.67128.3042.1113.9258.227.160.96
Total Current Liabilities404.43221.3788.4747.9479.2215.230.98
Long Term Debt1,115.759.468.673.654.120.000.00
Provision for Risks Charges0.000.000.000.000.000.000.00
Deferred Tax Liabilities28.8617.27-----
Other Liabilities64.740.000.023.012.630.3817.54
Total Liabilities1,613.78248.0997.1654.6085.9715.6118.52
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00249.960.00
Common Equity540.93476.72344.03311.74334.62-146.87186.24
Total Shareholders Equity540.93476.72344.03311.74334.62103.09186.24
Accumulated Minority Interest0.000.000.000.000.000.000.00
Total Equity540.93476.72344.03311.74334.62103.09186.24
Total Liabilities & Stockholders Equity2,154.70724.81441.19366.34420.58118.70204.77
Book Value Per Share2.382.161.611.501.63-3.197.40
Tangible Book Value Per Share0.291.451.010.860.97-3.197.40
Full-Time Employees2,4421,6371,046651398181-
Price to Book Ratio12.6211.975.744.284.012.521.27
Return on Assets8.9221.62-5.83-16.69-34.38-11.20-
Return on Equity25.2330.71-7.18-20.32-44.80-12.52-
Return on Invested Capital7.7525.92-6.68-20.82-31.78-17.573.25
Quick Ratio1.611.502.744.073.246.941.69
Current Ratio1.901.793.004.523.417.171.69

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-190.84128.37126.04-23.55-65.68-107.66-18.116.05
Depreciation107.7354.5017.099.527.474.081.06-
Other Funds (Non Cash)286.58159.2690.9866.7146.4669.1110.39-6.76
Funds from Operations163.86329.17172.4652.66-12.34-37.87-6.67-0.71
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital19.65-29.1678.6220.82-14.203.464.190.47
Cash from Operating Activities183.51300.01251.0873.48-26.53-34.41-2.48-0.24
Capital Expenditures-171.88-242.59-52.75-26.49-7.25-5.01-4.230.00
Net Assets From Acquisitions-341.56-145.23-15.400.000.00-46.470.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments583.78-637.1449.1014.3942.41-104.79-35.47-201.25
Purchase of Investments-43.50-745.84-160.56-157.24-187.70-266.63-95.01-201.25
Sale Or Maturity of Investments627.28108.70209.66171.62230.10161.8459.540.00
Other Uses-140.350.000.000.00-0.460.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-70.01-1,024.96-19.05-12.1134.70-156.27-39.70-201.25
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock-58.65-72.49-52.152.623.42164.8549.26203.06
Repurchase of Common Pref Stock-80.48-89.96-83.04-2.000.00-22.030.000.00
Sale of Common Pref Stock21.8417.4730.894.623.42186.8849.26203.06
Proceedsfrom Stock Options7.326.443.902.301.18184.8448.54203.06
Issuance or Reduction of Debt, Net349.31918.780.000.000.000.00-1.510.00
Change in Long Term Debt349.31918.780.000.000.000.000.000.00
Issuance of Long Term Debt386.06966.580.000.000.000.000.000.00
Reduction of Long Term Debt-36.75-47.800.000.000.000.000.000.00
Net Financing Active Other Cash Flow-146.63-116.67-55.69-14.10-36.5570.190.00-0.06
Other Financing Activities Uses-146.63-116.67-55.69-14.10-36.55-6.000.00-0.06
Cash from Financing Activities144.04729.62-107.84-11.47-33.13235.0447.74203.00
Exchange Rate Effect2.282.51-0.27-0.01-0.05-0.07-0.01-
Net Change in Cash259.837.18123.9249.89-25.0144.295.551.51
Free Cash Flow11.6357.41198.3346.99-33.78-39.42-6.71-0.24
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Price to Free Cash Flow598.72146.0428.8739.65----
Deferred Taxes & Investment Tax Credit--12.96-61.65-0.01-0.59-3.390.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments712.22841.05750.88577.49629.741,144.62
Short Term Receivables427.85375.29149.6232.1541.336.74
Inventories121.4699.7584.71115.73105.99141.80
Other Current Assets59.5868.5360.1642.2668.2062.42
Total Current Assets1,321.101,384.611,045.36767.64845.261,355.57
Net Property, Plant & Equipment567.94529.78478.09448.98406.74277.14
Total Investments and Advances0.000.000.00351.26438.340.37
Intangible Assets1,507.941,524.53603.87474.44454.17158.41
Deferred Tax Assets121.12111.5892.0982.7184.9284.23
Other Assets28.7678.3147.6229.683.881.87
Total Assets3,546.863,628.812,267.042,154.702,233.301,877.58
Short Term Debt Incl. Current Port. of LT Debt10.8511.555.584.843.423.13
Accounts Payable515.69501.30306.87143.28198.41105.01
Income Tax Payable24.9128.3114.079.648.304.95
Other Current Liabilities884.49942.08292.26246.67240.65159.14
Total Current Liabilities1,435.951,483.23618.78404.43450.79272.23
Long Term Debt1,549.911,534.691,126.461,115.751,114.601,041.25
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities27.9630.9323.5128.8631.21-
Other Liabilities177.75255.8952.1364.7455.731.40
Total Liabilities3,191.573,304.741,820.881,613.781,652.321,314.89
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity355.30324.07446.17540.93580.98562.70
Total Shareholders Equity355.30324.07446.17540.93580.98562.70
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity355.30324.07446.17540.93580.98562.70
Total Liabilities & Stockholders Equity3,546.863,628.812,267.042,154.702,233.301,877.58
Book Value Per Share1.521.391.932.382.552.49
Tangible Book Value Per Share-4.92-5.15-0.680.290.561.79
Full-Time Employees---2,442--
Price to Book Ratio12.6217.938.7212.7122.7620.29
Return on Assets-6.60-5.16-0.848.929.4416.42
Return on Equity-40.77-32.03-2.6625.2326.2141.88
Return on Invested Capital-1.73-4.64-5.861.240.932.65
Quick Ratio0.840.871.551.611.644.46
Current Ratio0.920.931.691.901.884.98

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-33.04-86.29-92.1120.6015.7742.51
Depreciation38.2129.4821.9518.0917.6710.46
Other Funds (Non Cash)73.0365.98106.0441.5253.9437.10
Funds from Operations65.41-0.1921.9176.7488.2580.61
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.02-35.7467.45-12.0460.12-101.53
Cash from Operating Activities65.39-35.9489.3664.70148.37-20.92
Capital Expenditures-39.42-32.25-36.32-63.88-69.36-50.31
Net Assets From Acquisitions0.00-180.24-137.87-23.45-116.670.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments124.34297.03158.743.66-701.3729.23
Purchase of Investments0.000.00-11.22-32.28-713.560.00
Sale Or Maturity of Investments124.34297.03169.9635.9412.1929.23
Other Uses-140.350.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-55.4284.54-15.45-83.68-887.40-21.09
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.2511.875.01-75.77-6.185.54
Repurchase of Common Pref Stock0.000.000.00-80.48-9.480.00
Sale of Common Pref Stock0.2511.875.014.713.305.54
Proceedsfrom Stock Options0.003.850.003.470.002.97
Issuance or Reduction of Debt, Net-0.27353.010.00-3.420.00922.20
Change in Long Term Debt-0.27353.010.00-3.420.00922.20
Issuance of Long Term Debt-0.27389.750.00-3.420.00970.00
Reduction of Long Term Debt0.00-36.750.000.000.00-47.80
Net Financing Active Other Cash Flow-18.91-23.12-82.89-21.71-32.48-36.76
Other Financing Activities Uses-18.91-23.12-82.89-21.71-32.48-36.76
Cash from Financing Activities-18.92341.76-77.88-100.91-38.66890.98
Exchange Rate Effect4.75-2.81-2.382.72-1.491.03
Net Change in Cash-4.21387.55-6.35-117.16-779.17849.99
Free Cash Flow25.97-68.1953.030.8279.02-71.24
Price to Free Cash Flow598.72124.2376.92140.31121.50109.91

Revenue breakdown

Services-Offices & Clinics of Doctors of Medicine2024: 1.48B 2025: 2.35B
Non-US2024: 26.84M 2025: 133.99M
United States2024: 1.45B 2025: 2.21B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3024.38%51.7M211.9M10.75M
2026-10-1525.24%53.5M211.9M12.15M
2026-09-3025.85%54.8M211.9M12.63M
2026-09-1524.98%52.9M211.8M14.01M
2026-08-3125.94%54.9M211.8M15.63M
2026-08-1427.90%58.7M210.3M16.84M
2026-07-3129.80%62.2M208.8M18.95M
2026-07-1529.41%61.4M208.8M23.60M
2026-06-3029.29%61.2M208.8M25.30M
2026-06-1531.36%65.5M208.8M26.76M
2026-05-2929.94%62.6M209.1M34.07M
2026-05-1530.30%63.4M209.2M35.93M
2026-04-3030.61%63.2M206.3M39.53M
2026-04-1533.82%69.8M206.3M35.34M
2026-03-3134.46%71.4M207.1M34.23M
2026-03-1340.22%83.3M207.1M30.76M
2026-02-2741.03%85.0M207.1M22.43M
2026-02-1339.12%81.0M207.1M20.96M
2026-01-3037.11%76.8M206.8M18.73M
2026-01-1534.95%72.3M206.7M20.38M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call15.004.105.503.555.47827.000.000.988-0.0190.000
call16.003.154.002.933.52331.000.000.933-0.0810.002
call17.002.172.822.702.4311106.000.913-0.0740.002
call17.501.792.141.901.23772.007.000.855-0.1060.003
call18.001.501.661.501.19727286.000.788-0.1300.004
call18.501.121.251.111.1411,5372100.698-0.1530.005
call19.000.830.940.821.1451,4302620.595-0.1650.006
call19.500.570.650.541.1498542370.484-0.1720.006
call20.000.370.420.411.1211,7701,3250.374-0.1590.006
call20.500.240.300.271.16581864.000.281-0.1450.005
call21.000.150.200.171.1671,3201190.194-0.1150.004
call21.500.080.140.141.28340628.000.150-0.1050.003
call22.000.050.110.061.3661,67640.000.117-0.0940.003
call22.500.030.060.051.3219418.000.072-0.0640.002
call23.000.020.040.021.3484,46446.000.050-0.0490.002
call23.500.020.030.031.4021,76126.000.038-0.0400.001
call24.000.010.040.031.5242,37710.000.035-0.0410.001
call24.500.010.030.031.6412,34114.000.033-0.0420.001
call25.000.010.020.011.6454,2242.000.023-0.0310.001
call25.500.000.050.031.7509220.000.022-0.0320.001
call26.000.000.030.031.8516,6811.000.021-0.0330.001
call26.500.000.030.011.9503,8780.000.020-0.0330.001
call27.000.000.040.022.0461,4477.000.019-0.0330.001
call27.500.000.050.012.1401,5980.000.018-0.0340.001
call28.000.000.030.042.2317,83232.000.018-0.0340.001
call28.500.000.030.012.3204,2881.000.017-0.0350.001
call29.000.000.010.012.3552,2686.000.017-0.0350.001
call29.500.000.200.022.4927225.000.016-0.0350.001
call30.000.000.010.012.0895,4602.000.009-0.0150.000
call30.500.010.020.022.4361,0463.000.009-0.0200.000
call31.000.000.010.012.2191,9790.000.009-0.0150.000
call31.500.000.300.012.5833430.000.008-0.0210.000
call32.000.010.020.012.6551,4555.000.008-0.0210.000
call32.500.000.020.012.7255610.000.008-0.0210.000
call33.000.000.010.012.7931,6572.000.008-0.0210.000
call33.500.000.010.012.8142981.000.008-0.0210.000
call34.000.000.160.012.9271,2600.000.008-0.0210.000
call34.500.000.510.012.9922050.000.007-0.0210.000
call35.000.000.010.013.0091,5532.000.007-0.0220.000
call35.500.010.020.063.1182480.000.007-0.0220.000
call36.000.000.510.013.1807030.000.007-0.0220.000
call36.500.000.510.013.2401130.000.007-0.0220.000
call37.000.000.010.013.3001,3600.000.007-0.0220.000
call37.500.000.240.013.3581570.000.007-0.0220.000
call38.000.000.180.013.4164190.000.007-0.0220.000
call38.500.000.510.063.4721240.000.007-0.0220.000
call39.000.000.200.013.5285570.000.006-0.0220.000
call39.500.000.510.013.58347.000.000.006-0.0220.000
call40.000.000.010.013.6371,4270.000.006-0.0230.000
put15.000.000.010.011.6081,4172.00-0.012-0.0170.000
put16.000.010.030.031.7502,37036.00-0.067-0.0790.002
put17.000.050.060.061.3022,631110-0.087-0.0720.002
put17.500.070.150.121.3111,4784.00-0.145-0.1040.003
put18.000.150.200.171.2782,005131-0.212-0.1280.004
put18.500.280.330.291.2874,012261-0.302-0.1510.005
put19.000.440.530.411.2582,29565.00-0.405-0.1630.006
put19.500.650.780.721.3287829.00-0.516-0.1700.006
put20.000.961.091.011.3455,21225.00-0.626-0.1570.006
put20.501.301.451.281.4515023.00-0.719-0.1420.005
put21.001.701.861.911.5418824.00-0.806-0.1130.004
put21.502.032.421.881.6073661.00-0.850-0.1020.003
put22.002.552.763.001.7082,7780.00-0.883-0.0920.003
put22.502.913.503.452.2001,9600.00-0.928-0.0610.002
put23.003.453.803.212.1261,2842.00-0.950-0.0460.002
put23.503.405.004.653.3666610.00-0.962-0.0380.001
put24.004.504.754.322.3021,6762.00-0.965-0.0390.001
put24.504.456.205.803.7402130.00-0.967-0.0400.001
put25.005.155.755.502.59898210.00-0.977-0.0290.001
put25.505.407.356.775.1213250.00-0.978-0.0290.001
put26.006.307.707.234.9968490.00-0.979-0.0300.001
put26.506.408.207.625.1622480.00-0.980-0.0300.001
put27.006.908.708.155.3235890.00-0.981-0.0300.001
put27.507.409.358.605.3732000.00-0.982-0.0310.001
put28.007.909.159.084.3381,3971.00-0.982-0.0310.001
put28.508.4010.209.825.7751100.00-0.983-0.0310.001
put29.008.9510.8010.206.1301,2090.00-0.983-0.0320.001
put29.509.4511.5510.675.49186.000.00-0.984-0.0320.001
put30.0010.0010.9510.504.2151,07150.00-0.991-0.0170.000
put30.5010.4012.5511.737.0577.000.00-0.991-0.0170.000
put31.0010.9012.8011.906.6662061.00-0.991-0.0170.000
put31.5011.4513.2012.846.57241.000.00-0.992-0.0170.000
put32.0011.9013.9013.347.1291790.00-0.992-0.0170.000
put32.5012.4014.0013.826.3448.000.00-0.992-0.0170.000
put33.0012.9014.9014.327.36822.000.00-0.992-0.0170.000
put33.5013.4015.0014.806.56710.000.00-0.992-0.0170.000
put34.0013.9016.0515.257.91611.000.00-0.992-0.0180.000
put34.5014.4016.6015.778.13213.000.00-0.993-0.0180.000
put35.0014.8017.0516.208.13798.000.00-0.993-0.0180.000
put35.5015.4017.5516.808.2446.000.00-0.993-0.0180.000
put36.0015.9018.0517.278.3490.000.00-0.993-0.0180.000
put36.5016.3518.7017.778.7684.000.00-0.993-0.0180.000
put37.0016.9019.2018.208.86911.000.00-0.993-0.0180.000
put37.5017.4019.5518.828.6516.000.00-0.993-0.0180.000
put38.0017.9020.0519.328.7488.000.00-0.993-0.0180.000
put38.5018.4020.5519.828.84315.000.00-0.993-0.0180.000
put39.0018.8521.0520.328.93717.000.00-0.994-0.0180.000
put39.5019.4021.7020.829.3513.000.00-0.994-0.0180.000
put40.0019.8522.2021.329.44218.000.00-0.994-0.0180.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-098-KCurrent report2026-11-04SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-10-30SCHEDULE 13G/ASEC
2026-10-294Statement of changes in beneficial ownership of securities2026-10-28SEC
2026-10-28144Filing for proposed sale of securities under Rule 144.SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-153Initial statement of beneficial ownership of securities2026-10-09SEC
2026-10-14144Filing for proposed sale of securities under Rule 144.SEC
2026-10-078-KCurrent report2026-10-07SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-01144Filing for proposed sale of securities under Rule 144.SEC
2026-09-30144Filing for proposed sale of securities under Rule 144.SEC
2026-09-234Statement of changes in beneficial ownership of securities2026-09-22SEC
2026-09-22144Filing for proposed sale of securities under Rule 144.SEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-17SEC
2026-09-174Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-174Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-17144Filing for proposed sale of securities under Rule 144.SEC
2026-09-174Statement of changes in beneficial ownership of securities2026-09-16SEC
2026-09-16144Filing for proposed sale of securities under Rule 144.SEC
2026-09-15144Filing for proposed sale of securities under Rule 144.SEC
2026-09-15144Filing for proposed sale of securities under Rule 144.SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-08-31SCHEDULE 13D/ASEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-25SEC
2026-08-204Statement of changes in beneficial ownership of securities2026-08-19SEC
2026-08-204Statement of changes in beneficial ownership of securities2026-08-18SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-1000255.53K3
2026-09002.23M7
2026-08001.57M4
2026-0700490.52K2
2026-06005.15M7
2026-051.17M1187.92K1
2026-04002.41M5
2026-03002.88M4
2026-0200209.85K2
2026-0100581.57K2
2025-12002.36M6
2025-11001.06M3

Institutional holders

Manager% owned
BlackRock, Inc.12.40%
VANGUARD PORTFOLIO MANAGEMENT LLC4.56%
VANGUARD CAPITAL MANAGEMENT LLC4.12%
STATE STREET CORP3.52%
MORGAN STANLEY3.09%
Divisadero Street Capital Management, LP2.60%
GEODE CAPITAL MANAGEMENT, LLC2.41%
GOLDMAN SACHS GROUP INC2.24%
JPMORGAN CHASE & CO2.06%
UBS Group AG2.04%

Funds

Fund% owned
iShares Core S&P Mid-Cap ETF3.13%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.90%
iShares Russell 2000 ETF2.40%
VANGUARD SMALL-CAP INDEX FUND2.10%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.21%
Advent Convertible & Income Fund1.18%
VANGUARD EXTENDED MARKET INDEX FUND1.05%
iShares Russell 2000 Growth ETF0.86%
JPMorgan Large Cap Growth Fund0.85%
State Street SPDR S&P MidCap 400SM ETF Trust0.70%

OakChart. HIMS. Cached 15 minutes.